| ORR | Name: | 1-(5-amino-3,4-dihydro-1,7-naphthyridin-1(2H)-yl)-2-(3-chlorophenyl)ethan-1-one | Formula: | C16 H16 Cl N3 O | SMILES: | Clc1cccc(c1)CC(=O)N1CCCc2c1cncc2N | InChi: | InChI=1S/C16H16ClN3O/c17-12-4-1-3-11(7-12)8-16(21)20-6-2-5-13-14(18)9-19-10-15(13)20/h1,3-4,7,9-10H,2,5-6,8,18H2 | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 1-(5-amino-3,4-dihydro-1,7-naphthyridin-1(2H)-yl)-2-(3-chlorophenyl)ethan-1-one |
|
| OSI | Name: | (4R)-6-chloro-N-(isoquinolin-4-yl)-4-methyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide | Formula: | C20 H17 Cl N2 O2 | SMILES: | Clc1ccc2OCCC(C)(c2c1)C(=O)Nc1cncc2ccccc21 | InChi: | InChI=1S/C20H17ClN2O2/c1-20(8-9-25-18-7-6-14(21)10-16(18)20)19(24)23-17-12-22-11-13-4-2-3-5-15(13)17/h2-7,10-12H,8-9H2,1H3,(H,23,24)/t20-/m1/s1 | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (4R)-6-chloro-N-(isoquinolin-4-yl)-4-methyl-3,4-dihydro-2H-1-benzopyran-4-carboxamide |
|
| OT6 | Name: | 2-{3-chloro-5-[(2-cyano-2-methylpropyl)amino]phenyl}-N-(4-methylpyridin-3-yl)acetamide | Formula: | C19 H21 Cl N4 O | SMILES: | O=C(Nc1cnccc1C)Cc1cc(NCC(C)(C)C#N)cc(Cl)c1 | InChi: | InChI=1S/C19H21ClN4O/c1-13-4-5-22-10-17(13)24-18(25)8-14-6-15(20)9-16(7-14)23-12-19(2,3)11-21/h4-7,9-10,23H,8,12H2,1-3H3,(H,24,25) | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-{3-chloro-5-[(2-cyano-2-methylpropyl)amino]phenyl}-N-(4-methylpyridin-3-yl)acetamide |
|
| OTV | Name: | 2-(3-chloro-5-{[(1S,2R)-2-(trifluoromethyl)cyclopropyl]amino}phenyl)-N-(4-methylpyridin-3-yl)acetamide | Formula: | C18 H17 Cl F3 N3 O | SMILES: | O=C(Nc1cnccc1C)Cc1cc(NC2CC2C(F)(F)F)cc(Cl)c1 | InChi: | InChI=1S/C18H17ClF3N3O/c1-10-2-3-23-9-16(10)25-17(26)6-11-4-12(19)7-13(5-11)24-15-8-14(15)18(20,21)22/h2-5,7,9,14-15,24H,6,8H2,1H3,(H,25,26)/t14-,15+/m1/s1 | Definition date: | 2023-08-17 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chloro-5-{[(1S,2R)-2-(trifluoromethyl)cyclopropyl]amino}phenyl)-N-(4-methylpyridin-3-yl)acetamide |
|
| OTY | Name: | 2-hydroxy-L-tyrosine | Formula: | C9 H11 N O4 | SMILES: | O=C(O)C(N)Cc1ccc(O)cc1O | InChi: | InChI=1S/C9H11NO4/c10-7(9(13)14)3-5-1-2-6(11)4-8(5)12/h1-2,4,7,11-12H,3,10H2,(H,13,14)/t7-/m0/s1 | Definition date: | 2006-11-21 | Last modified: | 2023-11-03 | Identifier: | 2-hydroxy-L-tyrosine |
|
| OTZ | Name: | 2-[2-(aminomethyl)-1,3-oxazol-4-yl]-1,3-thiazole-4-carboxylic acid | Formula: | C8 H7 N3 O3 S | SMILES: | NCc1occ(n1)c2scc(n2)C(O)=O | InChi: | InChI=1S/C8H7N3O3S/c9-1-6-10-4(2-14-6)7-11-5(3-15-7)8(12)13/h2-3H,1,9H2,(H,12,13) | Definition date: | 2018-06-04 | Last modified: | 2023-11-03 | Release date: | 2019-01-30 | Identifier: | 2-[2-(aminomethyl)-1,3-oxazol-4-yl]-1,3-thiazole-4-carboxylic acid |
|
| OUD | Name: | (3~{S})-3-azanyl-4-(carboxyamino)butanoic acid | Formula: | C5 H10 N2 O4 | SMILES: | N[CH](CNC(O)=O)CC(O)=O | InChi: | InChI=1S/C5H10N2O4/c6-3(1-4(8)9)2-7-5(10)11/h3,7H,1-2,6H2,(H,8,9)(H,10,11)/t3-/m0/s1 | Definition date: | 2017-02-10 | Last modified: | 2023-11-03 | Release date: | 2017-04-12 | Identifier: | (3~{S})-3-azanyl-4-(carboxyamino)butanoic acid |
|
| OUE | Name: | (4~{S})-4-azanyl-5-(carboxyamino)pentanoic acid | Formula: | C6 H12 N2 O4 | SMILES: | N[CH](CCC(O)=O)CNC(O)=O | InChi: | InChI=1S/C6H12N2O4/c7-4(1-2-5(9)10)3-8-6(11)12/h4,8H,1-3,7H2,(H,9,10)(H,11,12)/t4-/m0/s1 | Definition date: | 2017-02-10 | Last modified: | 2023-11-03 | Release date: | 2017-04-12 | Identifier: | (4~{S})-4-azanyl-5-(carboxyamino)pentanoic acid |
|
| OUF | Name: | N-[(furan-2-yl)methyl]-N'-(2-methyl-1-oxo-1,2-dihydroisoquinolin-4-yl)-N-{3-[(propan-2-yl)oxy]propyl}urea | Formula: | C22 H27 N3 O4 | SMILES: | O=C1c2ccccc2C(=CN1C)NC(=O)N(CCCOC(C)C)Cc1ccco1 | InChi: | InChI=1S/C22H27N3O4/c1-16(2)28-13-7-11-25(14-17-8-6-12-29-17)22(27)23-20-15-24(3)21(26)19-10-5-4-9-18(19)20/h4-6,8-10,12,15-16H,7,11,13-14H2,1-3H3,(H,23,27) | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-[(furan-2-yl)methyl]-N'-(2-methyl-1-oxo-1,2-dihydroisoquinolin-4-yl)-N-{3-[(propan-2-yl)oxy]propyl}urea |
|
| OUH | Name: | [(2~{S})-2-azanyl-3-(1~{H}-imidazol-5-yl)propyl]carbamic acid | Formula: | C7 H12 N4 O2 | SMILES: | N[CH](CNC(O)=O)Cc1[nH]cnc1 | InChi: | InChI=1S/C7H12N4O2/c8-5(2-10-7(12)13)1-6-3-9-4-11-6/h3-5,10H,1-2,8H2,(H,9,11)(H,12,13)/t5-/m0/s1 | Definition date: | 2017-02-10 | Last modified: | 2023-11-03 | Release date: | 2017-04-12 | Identifier: | [(2~{S})-2-azanyl-3-(1~{H}-imidazol-5-yl)propyl]carbamic acid |
|
| OUI | Name: | [(2~{S},3~{S})-2-azanyl-3-methyl-pentyl]carbamic acid | Formula: | C7 H16 N2 O2 | SMILES: | CC[CH](C)[CH](N)CNC(O)=O | InChi: | InChI=1S/C7H16N2O2/c1-3-5(2)6(8)4-9-7(10)11/h5-6,9H,3-4,8H2,1-2H3,(H,10,11)/t5-,6+/m0/s1 | Definition date: | 2017-02-10 | Last modified: | 2023-11-03 | Release date: | 2017-04-12 | Identifier: | [(2~{S},3~{S})-2-azanyl-3-methyl-pentyl]carbamic acid |
|
| OUK | Name: | [(5~{S})-5-azanyl-6-(carboxyamino)hexyl]azanium | Formula: | C7 H18 N3 O2 | SMILES: | N[CH](CCCC[NH3+])CNC(O)=O | InChi: | InChI=1S/C7H17N3O2/c8-4-2-1-3-6(9)5-10-7(11)12/h6,10H,1-5,8-9H2,(H,11,12)/p+1/t6-/m0/s1 | Definition date: | 2017-02-10 | Last modified: | 2023-11-03 | Release date: | 2017-04-12 | Identifier: | [(5~{S})-5-azanyl-6-(carboxyamino)hexyl]azanium |
|
| OV4 | Name: | 2-(1H-benzotriazol-1-yl)-N-benzyl-N-[4-(dimethylamino)phenyl]acetamide | Formula: | C23 H23 N5 O | SMILES: | CN(C)c1ccc(cc1)N(Cc1ccccc1)C(=O)Cn1nnc2ccccc21 | InChi: | InChI=1S/C23H23N5O/c1-26(2)19-12-14-20(15-13-19)27(16-18-8-4-3-5-9-18)23(29)17-28-22-11-7-6-10-21(22)24-25-28/h3-15H,16-17H2,1-2H3 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(1H-benzotriazol-1-yl)-N-benzyl-N-[4-(dimethylamino)phenyl]acetamide |
|
| OV7 | Name: | (2R)-amino[(carboxymethyl)sulfanyl]acetic acid | Formula: | C4 H7 N O4 S | SMILES: | NC(C(O)=O)SCC(O)=O | InChi: | InChI=1S/C4H7NO4S/c5-3(4(8)9)10-1-2(6)7/h3H,1,5H2,(H,6,7)(H,8,9)/t3-/m1/s1 | Definition date: | 2019-07-08 | Last modified: | 2023-11-03 | Release date: | 2019-08-07 | Identifier: | (2R)-amino[(carboxymethyl)sulfanyl]acetic acid |
|
| OVF | Name: | 2-(1H-benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-[4-(dimethylamino)phenyl]acetamide | Formula: | C23 H22 Cl N5 O | SMILES: | CN(C)c1ccc(cc1)N(Cc1cccc(Cl)c1)C(=O)Cn1nnc2ccccc21 | InChi: | InChI=1S/C23H22ClN5O/c1-27(2)19-10-12-20(13-11-19)28(15-17-6-5-7-18(24)14-17)23(30)16-29-22-9-4-3-8-21(22)25-26-29/h3-14H,15-16H2,1-2H3 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(1H-benzotriazol-1-yl)-N-[(3-chlorophenyl)methyl]-N-[4-(dimethylamino)phenyl]acetamide |
|
| OVX | Name: | 1-(3-chlorophenyl)-4-(isoquinoline-4-carbonyl)piperazin-2-one | Formula: | C20 H16 Cl N3 O2 | SMILES: | O=C(c1cncc2ccccc21)N1CC(=O)N(CC1)c1cccc(Cl)c1 | InChi: | InChI=1S/C20H16ClN3O2/c21-15-5-3-6-16(10-15)24-9-8-23(13-19(24)25)20(26)18-12-22-11-14-4-1-2-7-17(14)18/h1-7,10-12H,8-9,13H2 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 1-(3-chlorophenyl)-4-(isoquinoline-4-carbonyl)piperazin-2-one |
|
| OWC | Name: | (3S)-3-(3-chlorophenyl)-1-(isoquinolin-4-yl)piperidin-2-one | Formula: | C20 H17 Cl N2 O | SMILES: | Clc1cccc(c1)C1CCCN(c2cncc3ccccc23)C1=O | InChi: | InChI=1S/C20H17ClN2O/c21-16-7-3-6-14(11-16)18-9-4-10-23(20(18)24)19-13-22-12-15-5-1-2-8-17(15)19/h1-3,5-8,11-13,18H,4,9-10H2/t18-/m0/s1 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (3S)-3-(3-chlorophenyl)-1-(isoquinolin-4-yl)piperidin-2-one |
|
| OWF | Name: | (3S)-3-hydroxy-D-asparagine | Formula: | C4 H8 N2 O4 | SMILES: | NC(=O)C(O)C(N)C(O)=O | InChi: | InChI=1S/C4H8N2O4/c5-1(4(9)10)2(7)3(6)8/h1-2,7H,5H2,(H2,6,8)(H,9,10)/t1-,2+/m1/s1 | Definition date: | 2022-05-18 | Last modified: | 2023-11-03 | Release date: | 2023-01-11 | Identifier: | (3S)-3-hydroxy-D-asparagine |
|
| OWX | Name: | 2-(3-chlorophenyl)-N-(1,2,3,4-tetrahydro-1,7-naphthyridin-5-yl)acetamide | Formula: | C16 H16 Cl N3 O | SMILES: | Clc1cccc(c1)CC(=O)Nc1cncc2NCCCc12 | InChi: | InChI=1S/C16H16ClN3O/c17-12-4-1-3-11(7-12)8-16(21)20-15-10-18-9-14-13(15)5-2-6-19-14/h1,3-4,7,9-10,19H,2,5-6,8H2,(H,20,21) | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | 2-(3-chlorophenyl)-N-(1,2,3,4-tetrahydro-1,7-naphthyridin-5-yl)acetamide |
|
| OYF | Name: | (4R)-6-chloro-N-(2,7-naphthyridin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide | Formula: | C18 H14 Cl N3 O2 | SMILES: | Clc1ccc2OCCC(c2c1)C(=O)Nc1cncc2cnccc21 | InChi: | InChI=1S/C18H14ClN3O2/c19-12-1-2-17-15(7-12)14(4-6-24-17)18(23)22-16-10-21-9-11-8-20-5-3-13(11)16/h1-3,5,7-10,14H,4,6H2,(H,22,23)/t14-/m1/s1 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (4R)-6-chloro-N-(2,7-naphthyridin-4-yl)-3,4-dihydro-2H-1-benzopyran-4-carboxamide |
|
| OYL | Name: | 1-ethyl-L-histidine | Formula: | C8 H13 N3 O2 | SMILES: | O=C(O)C(N)Cc1ncn(c1)CC | InChi: | InChI=1S/C8H13N3O2/c1-2-11-4-6(10-5-11)3-7(9)8(12)13/h4-5,7H,2-3,9H2,1H3,(H,12,13)/t7-/m0/s1 | Definition date: | 2014-02-28 | Last modified: | 2023-11-03 | Release date: | 2014-06-25 | Identifier: | 1-ethyl-L-histidine |
|
| OYX | Name: | N-(2-cyclohexylethyl)-2-(isoquinolin-4-yl)-N-[(thiophen-2-yl)methyl]acetamide | Formula: | C24 H28 N2 O S | SMILES: | O=C(Cc1cncc2ccccc21)N(CCC1CCCCC1)Cc1cccs1 | InChi: | InChI=1S/C24H28N2OS/c27-24(15-21-17-25-16-20-9-4-5-11-23(20)21)26(18-22-10-6-14-28-22)13-12-19-7-2-1-3-8-19/h4-6,9-11,14,16-17,19H,1-3,7-8,12-13,15,18H2 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | N-(2-cyclohexylethyl)-2-(isoquinolin-4-yl)-N-[(thiophen-2-yl)methyl]acetamide |
|
| OZ3 | Name: | 5-(aminomethyl)-3~{H}-isoindol-2-ium-1-amine | Formula: | C9 H12 N3 | SMILES: | NCc1ccc2C(=[NH+]Cc2c1)N | InChi: | InChI=1S/C9H11N3/c10-4-6-1-2-8-7(3-6)5-12-9(8)11/h1-3H,4-5,10H2,(H2,11,12)/p+1 | Definition date: | 2022-09-28 | Last modified: | 2023-11-03 | Release date: | 2023-10-04 | Identifier: | 5-(aminomethyl)-3~{H}-isoindol-2-ium-1-amine |
|
| OZC | Name: | (3S)-3-(4-chlorophenyl)-1-(isoquinolin-4-yl)piperidin-2-one | Formula: | C20 H17 Cl N2 O | SMILES: | Clc1ccc(cc1)C1CCCN(c2cncc3ccccc23)C1=O | InChi: | InChI=1S/C20H17ClN2O/c21-16-9-7-14(8-10-16)18-6-3-11-23(20(18)24)19-13-22-12-15-4-1-2-5-17(15)19/h1-2,4-5,7-10,12-13,18H,3,6,11H2/t18-/m0/s1 | Definition date: | 2023-08-18 | Last modified: | 2023-11-03 | Release date: | 2023-11-08 | Identifier: | (3S)-3-(4-chlorophenyl)-1-(isoquinolin-4-yl)piperidin-2-one |
|
| 5BV | Name: | (2R,3R)-3-(glycyloxy)-2-methylnonanoic acid | Formula: | C12 H23 N O4 | SMILES: | O=C(OC(C(C)C(=O)O)CCCCCC)CN | InChi: | InChI=1S/C12H23NO4/c1-3-4-5-6-7-10(9(2)12(15)16)17-11(14)8-13/h9-10H,3-8,13H2,1-2H3,(H,15,16)/t9-,10-/m1/s1 | Definition date: | 2015-09-03 | Last modified: | 2023-11-03 | Release date: | 2016-03-02 | Identifier: | (2R,3R)-3-(glycyloxy)-2-methylnonanoic acid |
|